Agnieszka Giżewska

Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml

Ewa Witkowska-Patena, Agnieszka Giżewska, Mirosław Dziuk et al. · Prostate Cancer and Prostatic Diseases · 2019 · 43 citations

Positron Emission Tomography, Urology, Oncologic Imaging +10

The Utility of Hybrid SPECT/CT Lung Perfusion Scintigraphy in Pulmonary Embolism Diagnosis

Andrzej Mazurek, Mirosław Dziuk, Ewa Witkowska-Patena et al. · Respiration · 2015 · 41 citations · Full text

Impact of [18F]Fluorodeoxyglucose PET-CT Staging on Treatment Planning in Radiotherapy Incorporating Elective Nodal Irradiation for Non-Small-Cell Lung Cancer: A Prospective Study

Lucyna Kępka, Mirosław Dziuk, Anna Zawadzka et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 36 citations

Adaptive Radiotherapy, Nuclear Medicine, Non-small-cell Lung Cancer +12

Head-to-Head Comparison of 18F-Prostate-Specific Membrane Antigen-1007 and 18F-Fluorocholine PET/CT in Biochemically Relapsed Prostate Cancer

Ewa Witkowska-Patena, Agnieszka Giżewska, Mirosław Dziuk et al. · Clinical Nuclear Medicine · 2019 · 31 citations

Ordered subset expectation maximisation vs Bayesian penalised likelihood reconstruction algorithm in 18F-PSMA-1007 PET/CT

Ewa Witkowska-Patena, Anna Budzyńska, Agnieszka Giżewska et al. · Annals of Nuclear Medicine · 2020 · 25 citations · Full text